COMP <GO>
BNR vs ABBV // 10Y YIELD & FRED MACRO BETA
Burning Rock Biotech Limited (NASDAQ) VS. AbbVie Inc. (NYSE) • 15-METRIC TALLY: BNR 2
— ABBV 9
■ METRIC PARITY
LAST: $11.05 (-9.87%) • MKT CAP: $116.5M
macro-sensitivity
—
LAST: $290.79 (+1.68%) • MKT CAP: $513.86B
macro-sensitivity
1.15
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BNR VS. ABBV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BNR | ABBV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 74.70% | 70.20% | +4.50 | BNR | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 29.00% | -64.00 | ABBV | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 33.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -4.14% | 3.47% | -7.61 | ABBV | /fcf-yield <GO> |
| Operating Margin | -10.20% | 24.60% | -34.80 | ABBV | /operating-margins <GO> |
| Net Profit Margin | -10.30% | 6.90% | -17.20 | ABBV | /net-margins <GO> |
| Revenue Growth (YoY) | 9.20% | 8.60% | +0.60 | BNR | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.27% | -2.27 | ABBV | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 5.33 | -5.13 | ABBV | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | ABBV | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 38.2 | 65.1 | -26.94 | ABBV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | 1.15 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 113.1x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $116.5M | $513.86B | -$513.74B | ABBV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BNR REV | ABBV REV | BNR GROSS % | ABBV GROSS % | BNR FCF | ABBV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $77.2M | $61.16B | 74.7% | 70.2% | -$4.8M | $17.82B |
| FY 2024 | $70.7M | $56.33B | 70.3% | 70.0% | -$13.4M | $17.83B |
| FY 2023 | $75.7M | $54.32B | — | — | -$36.0M | $20.39B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BNR // BETA —
ABBV // BETA 1.15